Literature DB >> 8699056

Detection of human herpesvirus 8 DNA sequences before the appearance of Kaposi's sarcoma in human immunodeficiency virus (HIV)-positive subjects with a known date of HIV seroconversion.

J J Lefrère1, M C Meyohas, M Mariotti, J L Meynard, M Thauvin, J Frottier.   

Abstract

The presence of human herpesvirus 8 (HHV-8) DNA sequences was sought by polymerase chain reaction (PCR) in peripheral blood mononuclear cells of 4 groups: 6 human immunodeficiency virus (HIV)-infected persons with well-defined dates of seroconversion, during the period between the diagnosis of HIV infection and the appearance of Kaposi's sarcoma (KS); 45 HIV-positive persons with no symptoms of HIV infection; 11 AIDS patients with KS; and 14 AIDS patients without KS. HHV-8 DNA PCR was positive in 3 of the 6 patients during HIV infection preceding the appearance of KS and in all but 1 of 11 AIDS patients with KS. HHV-8 DNA PCR was negative in all but 1 of the 45 HIV-positive persons with no symptoms of infection and in all but 1 AIDS patient without KS. These results indicate that HHV-8 DNA may be detected several years before the occurrence of KS in HIV-infected subjects.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8699056     DOI: 10.1093/infdis/174.2.283

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  9 in total

1.  Kaposi's sarcoma-like tumors in a human herpesvirus 8 ORF74 transgenic mouse.

Authors:  Hong-Guang Guo; Mariola Sadowska; William Reid; Erwin Tschachler; Gary Hayward; Marvin Reitz
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

2.  Activation of NF-kappaB by the human herpesvirus 8 chemokine receptor ORF74: evidence for a paracrine model of Kaposi's sarcoma pathogenesis.

Authors:  S Pati; M Cavrois; H G Guo; J S Foulke; J Kim; R A Feldman; M Reitz
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

3.  Calibrated real-time PCR assay for quantitation of human herpesvirus 8 DNA in biological fluids.

Authors:  Francesco Broccolo; Giuseppe Locatelli; Loredana Sarmati; Sara Piergiovanni; Fabrizio Veglia; Massimo Andreoni; Stefano Buttò; Barbara Ensoli; Paolo Lusso; Mauro S Malnati
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

4.  Characterization of human herpesvirus 8 ORF59 protein (PF-8) and mapping of the processivity and viral DNA polymerase-interacting domains.

Authors:  S R Chan; B Chandran
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

5.  RBP-J (CSL) is essential for activation of the K14/vGPCR promoter of Kaposi's sarcoma-associated herpesvirus by the lytic switch protein RTA.

Authors:  Yuying Liang; Don Ganem
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

Review 6.  Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseases.

Authors:  Dharam V Ablashi; Louise G Chatlynne; James E Whitman; Ethel Cesarman
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

7.  Tumorigenesis by human herpesvirus 8 vGPCR is accelerated by human immunodeficiency virus type 1 Tat.

Authors:  Hong-Guang Guo; Shibani Pati; Mariola Sadowska; Man Charurat; Marvin Reitz
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

8.  Summary of the II International Consensus Symposium on Combined Antiviral Therapy and implications for future therapies.

Authors:  M D de Jong; C A Boucher; D A Cooper; G J Galasso; B Gazzard; J M Lange; J S Montaner; D D Richman; H C Thomas
Journal:  Antiviral Res       Date:  1997-07       Impact factor: 5.970

Review 9.  Laboratory diagnosis of human herpesvirus 8 infection in humans.

Authors:  R Tedeschi; J Dillner; P De Paoli
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2002-12-11       Impact factor: 5.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.